Roche’s R&D is moving on up. The pharma giant has opened two new high-rises in Basel, Switzerland, according to a Sept. 10 ...

Warren Biddle hit the exit from his role as SVP, global head of commercial at Gilead’s CAR-T unit Kite Pharma to take on the ...

Genentech, a member of the Roche Group (SIX ... OPTIONS XII for the Control of Influenza Congress (September 29 - October 2, Brisbane, Australia). “Building on Xofluza’s established efficacy in ...

Ocrelizumab and hyaluronidase is now the first and only twice-yearly subcutaneous injection approved for relapsing multiple ...

The UC Santa Cruz Alumni Association is proud to present this year’s UCSC Alumni Awards honorees: George M. Kraw, Keith Curry ...

At a preschool or elementary school, a sandbox is a space where anyone can wander by and immediately start digging around, see what’s beneath the surface, maybe use shovels and pails to make whatever ...

The FDA approved Ocrevus Zunovo, a subcutaneous formulation of Ocrevus, for adults with relapsing forms of MS and PPMS ...

“Ocrevus Zunovo gives patients and providers another option for receiving Ocrevus, building on a decade of robust safety and efficacy data for Ocrevus in multiple sclerosis,” said Levi Garraway, MD, ...

Medical marketers are ready to move away from AI as a buzzword while sports marketing opportunities emerge at Digital Pharma ...

Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell ...

Roche announces phase III CENTERSTONE study of Xofluza significantly reduces the transmission of influenza viruses: Basel Friday, September 20, 2024, 09:00 Hrs [IST] Roche announc ...